Pharmaceutical Business review

Sigma-Aldrich posts 15% rise in Q4 net profit

Revenue increased 5% to $610m including 2% points from acquisitions, the company repoted.

The company’s research-chemicals segment, its biggest contributor to the top line, reported sales were up 3%, mostly owing to acquisitions.

Its fine chemicals business saw sales improve 8%, with acquisitions contributing 1% point to the growth.

Sigma-Aldrich is a supplier of chemical products and kits for high-tech scientific research.